Pharmasset

Did Gilead Sciences Make an $11 Billion Blunder?
Motley Fool
Sun, 12/9/18 - 03:53 pm
Gilead Sciences
Pharmasset
hepatitis C
How Shrewd of a Dealmaker Is Gilead Sciences? Just Look at Its Last 7 Acquisitions
Motley Fool
Sun, 07/9/17 - 11:45 am
Gilead Sciences
M&A
CV Therapeutics
CGI Pharma
Arresto Biosciences
Calistoga Pharmaceuticals
Pharmasset
YM BioSciences
EpiTherapeutics
A Look Back at 2 Successful Biotech Buyouts
Yahoo/GuruFocus
Mon, 02/22/16 - 09:37 am
Gilead Sciences
Pharmasset
Merck
Idenix
M&A
Gilead Bets on Hepatitis C Data to Back Pharmasset Deal
Bloomberg
Thu, 04/12/12 - 11:35 am
Gilead
hepatitis C
Pharmasset
BMS-790052
GS-7977
Hepatitis C Remains A Hot Play
Seeking Alpha
Mon, 02/27/12 - 12:01 pm
hepatitis C
Bristol-Myers Squibb
Novartis
Gilead
Inhibitex
Merck
Vertex
Pharmasset
Enanta
Friday's Overreaction Provides Great Entry Point For Gilead
Seeking Alpha
Tue, 02/21/12 - 09:01 am
Gilead
Vertex
hepatitis C
Pharmasset
PSI-7977
Analyzing 5 Biotech Stocks And Their Takeover Potential
Seeking Alpha
Fri, 01/13/12 - 10:33 am
Abbott Laboratories
Achillion
Alexion
Bristol-Myers Squibb
Gilead
GSK
Human Genome Sciences
Indenix
Inhibitex
JNJ
Pfizer
Vertex
Pharmasset
Gilead nears completion of Pharmasset deal
Yahoo/AP
Thu, 01/12/12 - 08:29 am
M&A
Pharmasset
Gilead
3 Reasons Hep C Premiums Might Not Last
Motley Fool
Tue, 01/10/12 - 09:50 am
hepatitis C
Anadys
Roche
Gilead
Pharmasset
Bristol-Myers Squibb
Inhibitex
A White Hot Hep C Market: What The Wags Say
Pharmalot
Mon, 01/9/12 - 01:24 pm
hepatitis C
Inhibitex
Bristol-Myers Squibb
Gilead
Pharmasset
M&A
Shares of hepatitis C drug developers rise on Bristol-Myers' $2.5B deal for Inhibitex
Yahoo/AP
Mon, 01/9/12 - 09:57 am
hepatitis C
Bristol-Myers Squibb
M&A
Inhibitex
Gilead
Pharmasset
Gilead Sciences Announces Early Termination of Hart-Scott-Rodino Waiting Period
Yahoo/BusinessWire
Sat, 01/7/12 - 01:23 pm
Gilead Sciences
Pharmasset
M&A
Pharmasset: M&A Presents Interesting Options Plays
Seeking Alpha
Wed, 01/4/12 - 09:36 am
M&A
Pharmasset
Gilead
Pharma winners of 2011 could keep surging next year
Investorplace
Wed, 12/28/11 - 12:08 pm
Amgen
Biogen Idec
Celgene
Gilead
Pharmasset
Alexion
Regeneron
Biotech Stock Mailbag: Most Important Events for 2012
TheStreet.com
Fri, 12/23/11 - 08:56 am
Oncothyreon
Keryx
Vical
Aeterna Zentaris
Eli Lilly
JNJ
Elan
Celgene
Pfizer
Gilead
Pharmasset
Threshold Pharmaceuticals
Celldex
Amgen
BioVex
Aveo Pharmaceutical
Amylin
Alkermes
Vertex
Cell Therapeutics
Amarin
ONYX Pharmaceuticals
Vivus
Health Care's Hottest Duo
Motley Fool
Wed, 12/21/11 - 09:01 am
Gilead
Pharmasset
hepatitis C
Achillion
Inhibitex
[video]4 Biotechs Dominating the Week
Motley Fool
Mon, 12/19/11 - 04:06 pm
YM BioSciences
BioSante
Pharmasset
Alexa
Five Drug Stock Winners of 2011
TheStreet.com
Mon, 12/19/11 - 10:01 am
Inhibitex
Questcor
Medivation
Pharmasset
Pharmacyclics
Inhibitex, Idenix rattled by rival's drug failure
MarketWatch
Sat, 12/17/11 - 11:23 am
Inhibitex
Idenix
PSI-938
Pharmasset
hepatitis C
Hep C Drug Panic! Pharmasset Stumble Ripples Through Sector
TheStreet.com
Fri, 12/16/11 - 11:29 am
Pharmasset
hepatitis C
Gilead
Inhibitex
PSI-938
Indenix

Pages